Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 USD | +2.68% |
|
-3.15% | +45.50% |
20/06 | Vanda rejects Future Pak and Cycle Pharma's takeover offers | RE |
19/06 | Cycle Pharmaceuticals Limited cancelled the acquisition of Vanda Pharmaceuticals Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.50% | 36Cr | |
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+23.73% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-16.52% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US